GAO Report: VA Pharmacy System Must Improve Ability to View, Exchange Data | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

GAO Report: VA Pharmacy System Must Improve Ability to View, Exchange Data

June 16, 2017
by Rajiv Leventhal
| Reprints

Department of Veterans Affairs (VA) pharmacists cannot always efficiently view necessary patient data among Veterans Health Administration (VHA) medical sites, according to a new report from the U.S. Government Accountability Office (GAO).

What’s more, the report concluded, pharmacists cannot transfer prescriptions to other VHA pharmacies or process prescription refills received from other VHA medical sites through the system. As a result, “The system does not provide important capabilities for pharmacists to make clinical decisions about prescriptions efficiently, which could negatively affect patient safety,” according to GAO.

Per Congressional mandates, GAO is required to examine VA's acquisition and use of a pharmacy system. For the study, GAO set out to determine whether VA currently possesses a functioning pharmacy system and the extent to which the system enables data to be viewed, shared, and transferred among VHA pharmacy locations; if VA's pharmacy system is interoperable with the Department of Defense’s (DOD's); and if VA has implemented its pharmacy system in accordance with healthcare industry practices.

As such, GAO analyzed documentation describing VA's pharmacy system; observed system demonstrations; analyzed plans and actions taken to achieve interoperability with DOD; and identified industry practices related to pharmacy systems, and compared them to VA's system capabilities.

In its attempts to be interoperable with DoD, VA has developed capabilities to exchange certain patient and medication information, according to the report. As an example, VA's pharmacy system has the ability to check prescription drug information from DOD.

Nevertheless, GAO concluded, limitations impede interoperability with DOD. For instance, VA clinicians and pharmacists cannot always view DOD patient data, and VA pharmacists do not always receive complete information from DOD to perform prescription checks on new medications. Also, the report stated, VA has not assessed the impact of its pharmacy system interoperability on service members transitioning from DOD to VA, and VHA officials stated that doing so would be difficult because there are other personnel related-factors that could affect patient care outcomes. “Without assessing the impact that pharmacy system interoperability is having on veterans, VA lacks assurance regarding the effectiveness of the system to adequately support its mission of providing healthcare to veterans,” the report attested.

Although VA's pharmacy system capabilities align with three of six identified healthcare industry practices, it lacks in three others, GAO said:

  • Pharmacists cannot electronically exchange prescriptions with non-VA providers and pharmacies. Therefore, veterans need to obtain paper prescriptions from external providers or have the providers fax the prescriptions to their local VA pharmacy to fill the prescriptions, which is time consuming and inefficient.
  • VA's system does not include certain clinical decision and workflow capabilities that, among other things, could improve clinicians' and pharmacists' ability to provide enhanced medical care to veterans. VA has indicated that it plans to implement such capabilities, but its plans for doing so are incomplete.
  • VA's system does not maintain a perpetual inventory management capability to monitor medication inventory levels. Therefore, pharmacists cannot effectively track when to reorder medications.

GAO has made six recommendations including that VA update its pharmacy system to view and receive complete medication data, assess the impact of interoperability, and implement additional industry practices. VA generally concurred with GAO's six recommendations, according to the report.

Get the latest information on Interoperability/Health and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Report: Aetna, Apple in Talks about Offering Plan Members Apple Watches

Aetna, which already offers the Apple Watch to its employees as part of a wellness program, is now in talks with Apple about pushing the wearable device to the health insurer’s members, according to a report in CNBC.

HIMSS Accepting Nominations for Most Influential Women in Health IT Awards

The Healthcare Information and Management Systems Society (HIMSS) has announced that nominations are now open for the HIMSS Most Influential Women in Health IT Awards.

E-Visits May Have Unintended Consequences for Docs, New Research Finds

Physicians who adopt e-visits often see increases in office visits and phone consultations, a reduction in new patients being seen by providers, and no noticeable improvements in patient health, according to new research.

CMS Provides More Details on Proposal to Eliminate Mandatory Bundled Payment Programs

The Centers for Medicare and Medicaid (CMS) posted a press release Tuesday that provides more details regarding its proposal to change the Comprehensive Care for Joint Replacement Model and cancel the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive payment model.

HHS Awards $105 Million to Community Health Centers for Quality Improvement

The U.S. Department of Health and Human Services (HHS) has awarded nearly $105 million to 1,333 health centers in all U.S. states, territories and the District of Columbia as an investment in quality improvement.

Survey: Healthcare Pros Challenged to Identify, Mitigate Medical Device Security Risks

More than one-third (36 percent) of surveyed professionals in the Internet of Things (IoT)-connected medical device ecosystem say their organizations have experienced a cybersecurity incident in the past year, according to a recent Deloitte poll.